Commitments and Contingencies (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |
|---|---|---|---|
Nov. 01, 2018 |
Mar. 31, 2019 |
Jun. 30, 2020 |
|
| CRO | |||
| Commitments and Contingencies | |||
| Expected term | 5 years | ||
| CRO Initial clinical trials | |||
| Commitments and Contingencies | |||
| Expected term | 2 years | ||
| Expected cost | $ 10,000 | ||
| Cost incurred | 3,004 | ||
| CRO Second clinical trials | |||
| Commitments and Contingencies | |||
| Expected term | 3 years | ||
| Expected cost | $ 8,000 | ||
| Cost incurred | 1,241 | ||
| Reimbursed cost (as a percent) | 50.00% | ||
| Second CRO | |||
| Commitments and Contingencies | |||
| Expected cost | $ 16,500 | ||
| Cost incurred | $ 16,296 |
| X | ||||||||||
- Definition The percentage of cost that will be reimbursed by another party. No definition available.
|
| X | ||||||||||
- Definition The minimum amount the entity agreed to spend under the long-term purchase commitment. No definition available.
|
| X | ||||||||||
- Definition Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|